Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
NOT_YET_RECRUITING
NA
60 participants
INTERVENTIONAL
2025-12-31
2029-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Comparison of Healthy Diets on Breast Cancer Markers
NCT02744079
Study of Biomarkers Associated With Fatigue in Patients With Early-Stage Breast Cancer Treated With Metformin or Placebo on NCIC-CTG-MA.32
NCT01286233
Nutrition-Related Biomarkers in Predicting Breast Cancer Risk in Women
NCT00900367
Evaluating the Association Between Changes in the Gut Microbiome, Fatigue, and Chemotherapy-Induced Nausea in Early Stage Breast Cancer
NCT05417867
Studying Changes in Breast Density in Patients With Early-Stage Breast Cancer Treated With Metformin Hydrochloride or Placebo on CAN-NCIC-MA.32
NCT01666171
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
OTHER
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Control
Regular Diet with Cancer-Related Wellness Education and Support
Control
Regular Diet with Cancer-Related Wellness Education and Support
Whole Food, Plant-Based Diet with Behavioral Education and Support
Whole Food, Plant-Based Diet with Behavioral Education and Support
Whole Food, Plant-Based Diet with Behavioral Education and Support
Whole Food, Plant-Based Diet with Behavioral Education and Support
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Control
Regular Diet with Cancer-Related Wellness Education and Support
Whole Food, Plant-Based Diet with Behavioral Education and Support
Whole Food, Plant-Based Diet with Behavioral Education and Support
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Treating oncologist approval and expected survival of at least six months
* Undergoing any systemic treatment including hormonal, cytotoxic, targeted monoclonal antibody or small molecule kinase inhibitors or any combination of the above. Women who have active cancer and have been recommended but declined systemic treatment are also eligible.
* Willing to adopt a strict, whole-foods, plant-based diet
* Willing and able to comply with the WFPB protocol for the duration of the study including scheduled testing, Zoom meetings, and office visits
* Able to speak and read English fluently.
* Women with plans for radiation therapy or surgery are also eligible provided that they meet all other eligibility criteria.
Exclusion Criteria
* Active malabsorption syndrome at time of consent, as determined by study physicians (i.e. Crohn's disease, bowel surgery)
* Any food allergies or intolerances that would interfere with study compliance
* Recent consumption (in the past six months) of a vegan diet
* eGFR \< 30 on ≥ two lab tests in the past six months
* Serum potassium \> 5.4 in the past six months
* Current insulin or sulfonylurea use
* Current warfarin use (non-vitamin K antagonist allowed)
* High-risk alcohol use (\>7 drinks/wk)
* Illicit substance use (not including marijuana)
* Cognitive impairment or psychiatric disorder impairing ability to give consent.
18 Years
FEMALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Rochester
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Thomas M Campbell
Assistant Professor (Part-Time) - Department of Family Medicine (SMD)
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Thomas M Campbell, MD
Role: PRINCIPAL_INVESTIGATOR
University of Rochester
Erin K Campbell, MD, MPH
Role: PRINCIPAL_INVESTIGATOR
University of Rochester
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
STUDY00010949
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.